Warren Averett Asset Management, LLC Haemonetics Corp Transaction History

Warren Averett Asset Management, LLC

  • $9.72 Billion
  • Q3 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$56.04 - $74.77 $24,769 - $33,048
442 Added 2.83%
16,066 $1.2 Million
Q1 2025

May 15, 2025
BUY
$59.34 - $80.05 $169,415 - $228,542
2,855 Added 22.36%
15,624 $992,000
Q4 2024

Feb 14, 2025
BUY
$71.16 - $93.38 $132,144 - $173,406
1,857 Added 17.02%
12,769 $997,000
Q3 2024

Nov 14, 2024
BUY
$72.45 - $91.58 $5,433 - $6,868
75 Added 0.69%
10,912 $876,000
Q2 2024

Aug 14, 2024
BUY
$81.24 - $97.37 $880,397 - $1.06 Million
10,837 New
10,837 $896,000

Others Institutions Holding HAE

# of Institutions
339
Shares Held
50.2M
Call Options Held
666K
Put Options Held
395K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Warren Averett Asset Management, LLC Portfolio

Follow Warren Averett Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Warren Averett Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Warren Averett Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email